{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:33:48Z","timestamp":1784126028222,"version":"3.55.0"},"reference-count":125,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Cyclodextrins, since their discovery in the late 19th century, have gained tremendous interest in biomedical research, beginning with their recognition as safe pharmaceutical excipients, and continuing with exploiting their potential for enhancing the therapeutic response of active pharmaceutical ingredients, and also to be used as drugs for specific medical purposes. This review presents an integrative perspective on amphiphilic cyclodextrins, the manuscript being divided into two parts, one devoted to the properties of amphiphilic cyclodextrins, while the second one is dedicated to their biomedical applications, with an emphasis on cancer therapy.<\/jats:p>","DOI":"10.3390\/pharmaceutics17081086","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T14:46:04Z","timestamp":1755787564000},"page":"1086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Potential of Amphiphilic Cyclodextrins as Carriers for Therapeutic Purposes: A Short Overview"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3187-3064","authenticated-orcid":false,"given":"Ramona Daniela","family":"P\u00e2rv\u0103nescu","sequence":"first","affiliation":[{"name":"Research Center for Experimental Pharmacology and Drug Design, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Pharmaceutical Chemistry, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4065-3650","authenticated-orcid":false,"given":"Marius","family":"P\u0103puric\u0103","sequence":"additional","affiliation":[{"name":"University Clinic of Anaesthesia and Intensive Care, Department X Surgery II, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ionica Oana","family":"Alexa","sequence":"additional","affiliation":[{"name":"Research Center for Experimental Pharmacology and Drug Design, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Pharmaceutical Chemistry, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adriana","family":"Dehelean","sequence":"additional","affiliation":[{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Clinic of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No.2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Codru\u021ba","family":"\u0218oica","sequence":"additional","affiliation":[{"name":"Research Center for Experimental Pharmacology and Drug Design, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Pharmacology-Pharmacotherapy, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-7028","authenticated-orcid":false,"given":"Elena Alina","family":"Moac\u0103","sequence":"additional","affiliation":[{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Clinic of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No.2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1863","authenticated-orcid":false,"given":"Adriana","family":"Lede\u021bi","sequence":"additional","affiliation":[{"name":"Advanced Instrumental Screening Center, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Analytical Chemistry, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Voicu","sequence":"additional","affiliation":[{"name":"Research Center for Experimental Pharmacology and Drug Design, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Pharmacology-Pharmacotherapy, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5760-8872","authenticated-orcid":false,"given":"Dorina","family":"Coricovac","sequence":"additional","affiliation":[{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Clinic of Toxicology, Drug Industry, Management and Legislation, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No.2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Trandafirescu","sequence":"additional","affiliation":[{"name":"Research Center for Experimental Pharmacology and Drug Design, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"},{"name":"University Department of Pharmaceutical Chemistry, Faculty of Pharmacy, \u201cVictor Babe\u0219\u201d University of Medicine and Pharmacy Timi\u0219oara, Eftimie Murgu Square No. 2, RO-300041 Timi\u0219oara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10311-018-0763-2","article-title":"Cyclodextrins, from molecules to applications","volume":"16","author":"Crini","year":"2018","journal-title":"Environ. Chem. Lett."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.11.018","article-title":"Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications","volume":"535","author":"Jansook","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Esteso, M.A., and Romero, C.M. (2024). Cyclodextrins: Properties and Applications. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25084547"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/nano4030741","article-title":"Nano-assemblies of modified cyclodextrins and their complexes with guest molecules: Incorporation in naostructured membranes and amphiphile nanoarchitectonics design","volume":"4","author":"Zerkoune","year":"2014","journal-title":"Nanomaterials"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3762\/bjnano.8.145","article-title":"Development of polycationic amphiphilic cyclodextrin nanoparticles for anticancer drug delivery","volume":"8","author":"Varan","year":"2017","journal-title":"Beilstein J. Nanotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2017.06.010","article-title":"Amphiphilic cyclodextrin nanoparticles","volume":"531","author":"Varan","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Vukomanovic, M., Gazvoda, L., Kurtjak, M., Hrescak, J., Jaklic, B., Moya-And\u00e9rico, L., Cendra, M.D.M., and Torrents, E. (2022). Development of a ternary cyclodextrin-arginine-ciprofloxacin antimicrobial complex with enhanced stability. Commun. Biol., 5.","DOI":"10.1038\/s42003-022-04197-9"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.addr.2007.05.012","article-title":"Cyclodextrins as pharmaceutical solubilizers","volume":"59","author":"Brewster","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.msec.2014.07.006","article-title":"A comparative study of the effect of \u03b1-, \u03b2-, and \u03b3-cyclodextrins as stabilizing agents in the synthesis of silver nanoparticles using a green chemistry method","volume":"43","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"P\u0103duraru, D.N., Niculescu, A.-G., Bolocan, A., Andronic, O., Grumezescu, A.M., and B\u00eerl\u0103, R. (2022). An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081748"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Braga, S.S. (2019). Cyclodextrins: Emerging Medicines of the New Millennium. Biomolecules, 9.","DOI":"10.3390\/biom9120801"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijpharm.2017.04.010","article-title":"Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye","volume":"531","author":"Loftsson","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Saokham, P., Muankaew, C., Jansook, P., and Loftsson, T. (2018). Solubility of Cyclodextrins and Drug\/Cyclodextrin Complexes. Molecules, 23.","DOI":"10.3390\/molecules23051161"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"P\u0103duraru, L., Panainte, A.-D., Peptu, C.-A., Apostu, M., Vieriu, M., Bibire, T., Sava, A., and Bibire, N. (2025). Smart drug delivery systems based on cyclodextrins and chitosan for cancer therapy. Pharmaceuticals, 18.","DOI":"10.3390\/ph18040564"},{"key":"ref_15","first-page":"627","article-title":"Cyclodextrins as multifunctional tools for advanced biomaterials in tissue repair and regeneration","volume":"49","author":"Lee","year":"2025","journal-title":"Bioact. Mater."},{"key":"ref_16","first-page":"1","article-title":"Cyclodextrins in Pharmacy. Chapter 1. Cyclodextrins, Chapter 2. Cyclodextrin Derivatives, and Chapter 4. Cyclodextrin Inclusion Complexes","volume":"Volume 5","author":"Davies","year":"1994","journal-title":"Topics in Inclusion Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10847-017-0752-2","article-title":"Application of cyclodextrins in cancer treatment","volume":"89","author":"Qiu","year":"2017","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dodziuk, H. (2006). Chapter 1. Molecules with Holes\u2014Cyclodextrins. Cyclodextrins and Their Complexes: Chemistry, Analytical Methods, Applications, Wiley Online Library.","DOI":"10.1002\/3527608982.ch1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpharm.2016.10.062","article-title":"\u03b3-Cyclodextrin","volume":"516","author":"Saokham","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Di Cagno, M.P. (2017). The Potential of Cyclodextrins as Novel Active Pharmaceutical Ingredients: A Short Overview. Molecules, 22.","DOI":"10.3390\/molecules22010001"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1208\/s12249-009-9375-2","article-title":"The role of L-arginine in inclusion complexes of omeprazole with cyclodextrins","volume":"11","author":"Figueiras","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"ref_22","first-page":"100211","article-title":"Formulation of multicomponent inclusion complex of cyclodextrin-amino acid with Chrysin: Physicochemical characterization, cell viability and apoptosis assessment in human primary glioblastoma cell line","volume":"6","author":"Mahdi","year":"2023","journal-title":"Int. J. Pharm. X"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sarabia-Vallejo, \u00c1., Caja, M.d.M., Olives, A.I., Mart\u00edn, M.A., and Men\u00e9ndez, J.C. (2023). Cyclodextrin inclusion complexes for improved drug bioavailability and activity: Synthetic and analytical aspects. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15092345"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1590\/1807-3107bor-2019.vol33.0112","article-title":"Doxycycline encapsulated in \u03b2-cyclodextrin for periodontitis: A clinical trial","volume":"33","author":"Trajano","year":"2020","journal-title":"Braz. Oral Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Torres-Alvarez, C., Castillo, S., S\u00e1nchez-Garc\u00eda, E., Aguilera Gonz\u00e1lez, C., Galindo-Rodr\u00edguez, S.A., Gabald\u00f3n-Hern\u00e1ndez, J.A., and B\u00e1ez-Gonz\u00e1lez, J.G. (2020). Inclusion Complexes of Concentrated Orange Oils and \u03b2-Cyclodextrin: Physicochemical and Biological Characterizations. Molecules, 25.","DOI":"10.3390\/molecules25215109"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.carbpol.2013.08.078","article-title":"Cyclodextrins as encapsulation agents for plant bioactive compounds","volume":"101","author":"Pinho","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/DDDT.S157611","article-title":"The hydroxypropyl-\u03b2-cyclodextrin complexation of toltrazuril for enhancing bioavailability","volume":"12","author":"Zhang","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijpharm.2009.11.035","article-title":"Self-assembled cyclodextrin aggregates and nanoparticles","volume":"387","author":"Messner","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s10973-020-09763-z","article-title":"Preparation, physicochemical characterization and biological activity evaluation of some inclusion complexes containing artesunate","volume":"141","author":"Vlase","year":"2020","journal-title":"J. Therm. Anal. Calorim."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.micron.2007.06.017","article-title":"Cyclodextrin-based aggregates and characterization by microscopy","volume":"39","author":"He","year":"2008","journal-title":"Micron"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"25876","DOI":"10.1021\/acsomega.1c04297","article-title":"Stimuli-Responsive Amphiphilic Pillar[n]arene Nanovesicles for Targeted Delivery of Cancer Drugs","volume":"6","author":"Fahmy","year":"2021","journal-title":"ACS Omega"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.06.055","article-title":"Cyclodextrins","volume":"453","author":"Kurkov","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014520830813","article-title":"The Driving Forces in the Inclusion Complexation of Cyclodextrins","volume":"42","author":"Liu","year":"2002","journal-title":"J. Incl. Phenom. Macrocycl. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"132467","DOI":"10.1016\/j.foodchem.2022.132467","article-title":"Cyclodextrins inclusion complex: Preparation methods, analytical techniques and food industry applications","volume":"384","author":"Rakmai","year":"2022","journal-title":"Food Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Loftsson, T., Sigurdsson, H.H., and Jansook, P. (2023). Anomalous properties of cyclodextrins and their complexes in aqueous solutions. Materials, 16.","DOI":"10.3390\/ma16062223"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"\u015euta, L.-M., Ridichie, A., Lede\u0163i, A., Temereanc\u0103, C., Lede\u0163i, I., Muntean, D., R\u0103dulescu, M., V\u0103ru\u0163, R.-M., Watz, C., and Cr\u0103ineanu, F. (2024). Host-Guest Complexation of Itraconazole with Cyclodextrins for Bioavailability Enhancement. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16040560"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejps.2013.04.002","article-title":"Biopharmaceutical classification of poorly soluble drugs with respect to \u201cenabling formulations\u201d","volume":"50","author":"Buckley","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Sb\u00e2rcea, L., T\u0103nase, I.-M., Lede\u021bi, A., C\u00eercioban, D., Vlase, G., Barvinschi, P., Micl\u0103u, M., V\u0103ru\u0163, R.-M., Trandafirescu, C., and Lede\u021bi, I. (2020). Encapsulation of Risperidone by Methylated \u03b2-Cyclodextrins: Physicochemical and Molecular Modeling Studies. Molecules, 25.","DOI":"10.3390\/molecules25235694"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"123539","DOI":"10.1016\/j.carbpol.2025.123539","article-title":"A recent update of water-soluble polymers in cyclodextrin-based formulations for mucosal drug delivery","volume":"358","author":"Hnin","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e39917","DOI":"10.1016\/j.heliyon.2024.e39917","article-title":"Advancements in cyclodextrin-based controlled drug delivery: Insights into pharmacokinetic and pharmacodynamic profiles","volume":"10","author":"Neaz","year":"2024","journal-title":"Heliyon"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"121500","DOI":"10.1016\/j.carbpol.2023.121500","article-title":"Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products","volume":"324","author":"Kali","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"123174","DOI":"10.1016\/j.carbpol.2024.123174","article-title":"Cyclodextrin-based delivery systems for chemical and genetic drugs: Current status and future","volume":"352","author":"Gao","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Musuc, A.M. (2024). Cyclodextrins: Advances in chemistry, toxicology, and multifaceted applications. Molecules, 29.","DOI":"10.3390\/molecules29225319"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2005.03.006","article-title":"Tamoxifen citrate loaded amphiphilic beta-cyclodextrin nanoparticles: In vitro characterization and cytotoxicity","volume":"104","author":"Vural","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijpharm.2007.06.051","article-title":"Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery","volume":"347","author":"Bilensoy","year":"2008","journal-title":"Int. J. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100869","DOI":"10.1016\/j.pmatsci.2021.100869","article-title":"Cyclodextrin-based nanostructures","volume":"124","author":"Narayanan","year":"2022","journal-title":"Prog. Mater. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13346-020-00724-5","article-title":"Cyclodextrins in drug delivery: Applications in gene and combination therapy","volume":"10","author":"Haley","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Karthic, A., Roy, A., Lakkakula, J., Alghamdi, S., Shakoori, A., Babalghith, A.O., Emran, T.B., Sharma, R., Lima, C.M.G., and Kim, B. (2022). Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review. Front. Cell Dev. Biol., 10.","DOI":"10.3389\/fcell.2022.984311"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Duchene, D., and Wouessidjewe, D. (1996). Amphiphilic Cyclodextrins and Targeting of Drugs. Proceedings of the Eighth International Symposium on Cyclodextrins, Budapest, Hungary, 31 March\u20132 April 1996, Kluwer Academic Publishers.","DOI":"10.1007\/978-94-011-5448-2_94"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.drudis.2015.05.008","article-title":"Cyclodextrin nanoassemblies: A promising tool for drug delivery","volume":"20","author":"Bonnet","year":"2015","journal-title":"Drug Discov. Today"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1039\/D0RA00299B","article-title":"Smart regioselectivity towards mono 6-hydroxyl \u03b1-cyclodextrin amphiphilic derivatives","volume":"10","author":"Cui","year":"2020","journal-title":"RSC Adv."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.colsurfa.2015.08.015","article-title":"Preparation and characterization of nanoparticles made fromamphiphilic mono and per-aminoalkyl-\u03b2-cyclodextrins","volume":"484","author":"Kalfat","year":"2015","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1208\/s12249-019-1572-z","article-title":"Synthesis, Characterization, and Drug Delivery Application of Self-assembling Amphiphilic Cyclodextrin","volume":"21","author":"Patel","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijpharm.2016.05.040","article-title":"Design and optimization of novel paclitaxel-loaded folate-conjugated amphiphilic cyclodextrin nanoparticles","volume":"509","author":"Nielsen","year":"2016","journal-title":"Int. J. Pharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.carres.2019.05.006","article-title":"Complex systems that incorporate cyclodextrins to get materials for some specific applications","volume":"480","author":"Silva","year":"2019","journal-title":"Carbohydr. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ijpharm.2017.04.050","article-title":"Cyclodextrin nanosystems in oral drug delivery: A mini review","volume":"531","author":"Adeoye","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"116880","DOI":"10.1016\/j.molliq.2021.116880","article-title":"Thiolated amphiphilic \u03b2-cyclodextrin-decorated gold colloids: Synthesis, supramolecular nanoassemblies and controlled release of dopamine","volume":"336","author":"Trapani","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"De Gaetano, F., Scala, A., Celesti, C., Lambertsen Larsen, K., Genovese, F., Bongiorno, C., Leggio, L., Iraci, N., Iraci, N., and Mazzaglia, A. (2023). Amphiphilic Cyclodextrin Nanoparticles as Delivery System for Idebenone: A Preformulation Study. Molecules, 28.","DOI":"10.3390\/molecules28073023"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"W\u00fcpper, S., L\u00fcersen, K., and Rimbach, G. (2021). Cyclodextrins, Natural Compounds, and Plant Bioactives\u2014A Nutritional Perspective. Biomolecules, 11.","DOI":"10.3390\/biom11030401"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1039\/D0NA00623H","article-title":"Amphiphilic cationic cyclodextrin nanovesicles: A versatile cue for guiding cell adhesion","volume":"2","author":"Valle","year":"2020","journal-title":"Nanoscale Adv."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Cho, E., Yun, D., Jeong, D., Im, J., Kim, H., Dindulkar, S.D., Choi, Y., and Jung, S. (2016). Regioselective self-acylating cyclodextrins in organic solvent. Sci. Rep., 6.","DOI":"10.1038\/srep23740"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.7150\/thno.31914","article-title":"Gene delivery based on macrocyclic amphiphiles","volume":"9","author":"Geng","year":"2019","journal-title":"Theranostics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2009.04.004","article-title":"Novel nanoparticles made from amphiphilic perfluoroalkyl alpha-cyclodextrin derivatives: Preparation, characterization and application to the transport of acyclovir","volume":"375","author":"Ghera","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejpb.2012.09.013","article-title":"Design, synthesis, and in vitro evaluation of new amphiphilic cyclodextrin-based nanoparticles for the incorporation and controlled release of acyclovir","volume":"83","author":"Perret","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijpharm.2012.11.004","article-title":"Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery","volume":"441","author":"Perret","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.addr.2013.05.001","article-title":"Cyclodextrin-based supramolecular systems for drug delivery: Recent progress and future perspective","volume":"65","author":"Zhang","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Spiridon, I., and Anghel, N. (2025). Cyclodextrins as multifunctional platforms in drug delivery and beyond: Structural features, functional applications, and future trends. Molecules, 30.","DOI":"10.3390\/molecules30143044"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejpb.2009.04.013","article-title":"Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery","volume":"73","author":"Bilensoy","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jddst.2015.07.019","article-title":"Amphiphilic cyclodextrins as enabling excipients for drug delivery and for decades of scientific collaboration: Tribute to a distinguished scientist, French representative and friend\u2014A historical perspective","volume":"30","author":"Yenice","year":"2015","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.colsurfb.2016.06.047","article-title":"Nanoassemblies based on non-ionic amphiphilic cyclodextrin hosting Zn(II)-phthalocyanine and docetaxel: Design, physicochemical properties and intracellular effects","volume":"146","author":"Conte","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Nicolaescu, O.E., Belu, I., Mocanu, A.G., Manda, V.C., R\u0103u, G., P\u00eervu, A.S., Ionescu, C., Ciulu-Costinescu, F., Popescu, M., and Cioc\u00eelteu, M.V. (2025). Cyclodextrins: Enhancing Drug Delivery, Solubility and Bioavailability for Modern Therapeutics. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17030288"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Ahlawat, J., Henriquez, G., and Narayan, M. (2018). Enhancing the Delivery of Chemotherapeutics: Role of Biodegradable Polymeric Nanoparticles. Molecules, 23.","DOI":"10.3390\/molecules23092157"},{"key":"ref_73","unstructured":"Kumar, M.N.V.R. (2007). Handbook of Particulate Drug Delivery, American Scientific Publishers."},{"key":"ref_74","first-page":"593","article-title":"Efficient size control of amphiphilic cyclodextrin nanoparticles through a statistical mixture design methodology","volume":"8","author":"Choisnard","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43094-022-00400-0","article-title":"Pharmaceutical nanotechnology: From the bench to the market","volume":"8","author":"Mazayen","year":"2022","journal-title":"Future J. Pharm. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s11671-024-04175-6","article-title":"Anti-inflammatory effects of cyclodextrin nanoparticles enable macrophage repolarization and reduce inflammation","volume":"19","author":"Brettner","year":"2024","journal-title":"Discov. Nano"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1039\/C9CC06545H","article-title":"Amphiphilic multi-charged cyclodextrins and vitamin K co-assembly as a synergistic coagulant","volume":"55","author":"Li","year":"2019","journal-title":"Chem. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/jps.22065","article-title":"Amphiphilic cyclodextrins as nanocarriers of genistein: A spectroscopic investigation pointing out the structural properties of the host\/drug complex system","volume":"99","author":"Stancanelli","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"102931","DOI":"10.1016\/j.jddst.2021.102931","article-title":"Cyclodextrin nanosponges as potential anticancer drug delivery systems to be introduced into the market, compared with liposomes","volume":"67","author":"Allahyari","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_80","first-page":"1","article-title":"Tumor microenvironment-responsive drug self-delivery systems to treat cancer and overcome MDR","volume":"44","author":"Li","year":"2025","journal-title":"Rare Met."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","article-title":"The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect","volume":"63","author":"Fang","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2018.09.002","article-title":"Engineering Nanoparticles for Targeted Delivery of Nucleic Acid Therapeutics in Tumor","volume":"12","author":"Xiao","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Wu, J. (2021). The Enhanced Permeability and Retention (EPR) Effect: The Significance of the Concept and Methods to Enhance Its Application. J. Pers. Med., 11.","DOI":"10.3390\/jpm11080771"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e21227","DOI":"10.1016\/j.heliyon.2023.e21227","article-title":"Nanoparticle-based materials in anticancer drug delivery: Current and future prospects","volume":"9","author":"Ajith","year":"2023","journal-title":"Heliyon"},{"key":"ref_85","first-page":"10","article-title":"Nanoparticle-based drug delivery systems for cancer therapy","volume":"1","author":"Dang","year":"2020","journal-title":"Smart Mater. Med."},{"key":"ref_86","first-page":"233","article-title":"An overview of nanoparticles in drug delivery: Properties and applications","volume":"46","author":"Hsu","year":"2023","journal-title":"S. Afr. J. Chem. Eng."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12249-024-02734-9","article-title":"Targeted Nanoparticles: The Smart Way for the Treatment of Colorectal Cancer","volume":"25","author":"Abdellatif","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2010.10.015","article-title":"Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model","volume":"403","author":"Cirpanli","year":"2011","journal-title":"Int. J. Pharm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1773-2247(05)50062-5","article-title":"Transcription efficiency of tamoxifen citrate-loaded \u03b2-cyclodextrin nanoparticles","volume":"15","author":"Vural","year":"2005","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"120379","DOI":"10.1016\/j.ijpharm.2021.120379","article-title":"Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level","volume":"598","author":"Ercan","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_92","first-page":"43903","article-title":"Nanoassembly of an Amphiphilic Cyclodextrin and Zn(II)-Phthalocyanine with the Potential for Photodynamic Therapy of Cancer","volume":"83","author":"Conte","year":"2013","journal-title":"RCS Adv."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Sabroso, C., Torres-Su\u00e1rez, A.I., Alonso-Gonz\u00e1lez, M., Fern\u00e1ndez-Carballido, A., and Fraguas-S\u00e1nchez, A.I. (2021). Active Targeted Nanoformulations via Folate Receptors: State of the Art and Future Perspectives. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010014"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41392-023-01642-x","article-title":"Smart nanoparticles for cancer therapy","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1021\/acs.molpharmaceut.4c00663","article-title":"Folate Receptor \u03b2 (FR\u03b2) Expression on Myeloid Cells and the Impact of Reticuloendothelial System on Folate-Functionalized Nanoparticles\u2019 Biodistribution in Cancer","volume":"21","author":"Goksen","year":"2024","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejpb.2013.06.011","article-title":"Targeted gene delivery by new folate-polycationic amphiphilic cyclodextrin-DNA nanocomplexes in vitro and in vivo","volume":"85","author":"Aranda","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1021\/acs.biomac.9b00306","article-title":"Folate-Decorated Amphiphilic Cyclodextrins as Cell-Targeted Nanophototherapeutics","volume":"20","author":"Zagami","year":"2019","journal-title":"Biomacromolecules"},{"key":"ref_98","first-page":"1143","article-title":"Therapeutic targeting in the silent era: Advances in non-viral siRNA delivery","volume":"6","author":"Guo","year":"2010","journal-title":"Mol. Biosyst."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Anjum, S., Ishaque, S., Fatima, H., Farooq, W., Hano, C., Abbasi, B.H., and Anjum, I. (2021). Emerging Applications of Nanotechnology in Healthcare Systems: Grand Challenges and Perspectives. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080707"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular Mechanisms and Biological Functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int. J. Biomed. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"de la Torre, C., J\u00e1tiva, P., Posadas, I., Manzanares, D., Blanco, J.L.J., Mellet, C.O., Fern\u00e1ndez, J.M.G., and Ce\u00f1a, V. (2022). A \u03b2-Cyclodextrin-Based Nanoparticle with Very High Transfection Efficiency Unveils siRNA-Activated TLR3 Responses in Human Prostate Cancer Cells. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14112424"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jconrel.2020.11.011","article-title":"Cyclodextrin based natural nanostructured carbohydrate polymers as effective non-viral siRNA delivery systems for cancer gene therapy","volume":"330","author":"Mousazadeh","year":"2021","journal-title":"J. Control. Release"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijpharm.2017.09.013","article-title":"Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours","volume":"532","author":"Evans","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"120888","DOI":"10.1016\/j.ijpharm.2021.120888","article-title":"A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer","volume":"606","author":"Zou","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1038\/s12276-023-01079-w","article-title":"Functional significance of cholesterol metabolism in cancer: From threat to treatment","volume":"55","author":"Xiao","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1038\/s41388-023-02836-x","article-title":"Dysregulation of cholesterol metabolism in cancer progression","volume":"42","author":"Liu","year":"2023","journal-title":"Oncogene"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"121940","DOI":"10.1016\/j.ijpharm.2022.121940","article-title":"A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU","volume":"623","author":"Varan","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Kovacs, T., Nagy, P., Panyi, G., Szente, L., Varga, Z., and Zakany, F. (2022). Cyclodextrins: Only Pharmaceutical Excipients or Full-Fledged Drug Candidates?. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14122559"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1021\/acs.molpharmaceut.0c01238","article-title":"Advances in the Design of (Nano) Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System","volume":"18","author":"Kont","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"103505","DOI":"10.1016\/j.drudis.2023.103505","article-title":"Design of lipid-based nanoparticles for delivery of therapeutic nucleic acids","volume":"28","author":"Kont","year":"2023","journal-title":"Drug Discov. Today"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biomaterials.2013.09.061","article-title":"Cyclodextrins in non-viral gene delivery","volume":"35","author":"Lai","year":"2014","journal-title":"Biomaterials"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"7263","DOI":"10.1016\/j.biomaterials.2011.06.025","article-title":"Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery","volume":"32","author":"Guilloteau","year":"2011","journal-title":"Biomaterials"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"125107","DOI":"10.1016\/j.ijpharm.2024.125107","article-title":"Structure-activity relationship of modified amphiphilic cationic cyclodextrins for enhanced siRNA delivery","volume":"670","author":"Kont","year":"2025","journal-title":"Int. J. Pharm."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2013.03.004","article-title":"Gene silencing of TNF-alpha in a murine model of acute colitis using a modified cyclodextrin delivery system","volume":"168","author":"McCarthy","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejps.2004.01.001","article-title":"Cell transfection with polycationic cyclodextrin vectors","volume":"21","author":"Cryan","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1517\/17425247.2011.610790","article-title":"Cyclodextrin-based siRNA delivery nanocarriers: A state-of-the-art review","volume":"8","author":"Chaturvedi","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/cn3000372","article-title":"Click-modified cyclodextrins as nonviral vectors for neuronal siRNA delivery","volume":"3","author":"Godinho","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1021\/acs.molpharmaceut.3c00769","article-title":"M2pep-Modified Cyclodextrin-siRNA Nanoparticles Modulate the Immunosuppressive Tumor Microenvironment for Prostate Cancer Therapy","volume":"20","author":"Sun","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Riccardi, C., Napolitano, F., Montesarchio, D., Sampaolo, S., and Melone, M.A.B. (2021). Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13111897"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Kont, A., Mendon\u00e7a, M.C.P., Cronin, M.F., Cahill, M.R., and O\u2019Driscoll, C.M. (2022). Co-Formulation of Amphiphilic Cationic and Anionic Cyclodextrins Forming Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukaemia. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179791"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2015.02.007","article-title":"Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysis","volume":"71","author":"Gooding","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1016\/j.biomaterials.2012.07.012","article-title":"Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice","volume":"33","author":"Guo","year":"2012","journal-title":"Biomaterials"},{"key":"ref_123","first-page":"4954","article-title":"A click chemistry route to 2-functionalised PEGylated and cationic \u03b2-cyclodextrins: Co-formulation opportunities for siRNA delivery","volume":"25","author":"Ogier","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejpb.2021.11.003","article-title":"Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model","volume":"169","author":"Cronin","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/med.20171","article-title":"Recent developments in carbohydrate-decorated targeted drug\/gene delivery","volume":"30","author":"Zhang","year":"2010","journal-title":"Med. Res. Rev."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/1086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:33:05Z","timestamp":1760034785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/8\/1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":125,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["pharmaceutics17081086"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17081086","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}